FindTrial
Sign In

Role of immunology in oral cancer

Immunohistochemical Expression of Endoglin(CD105) and Micro-Vessel Density in Oral Dysplasia and Squamous Cell Carcinoma-A Cross Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047147
Enrollment
64
Registered
2022-11-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

None listed

Sponsors

Rohilkhand Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All small and radical biopsies from oral cavity diagnosed histopathologically as normal oral mucosa, dysplasia and squamous cell carcinoma of any age and gender during the study period.

Exclusion criteria

Exclusion criteria: • All biopsies other than inclusion criteria • Inadequate biopsy specimen

Design outcomes

Primary

MeasureTime frame
To study expression of Endoglin (CD105) and micro-vessel density in oral dysplasia and squamous cell carcinoma.Timepoint: After operative procedure—

Secondary

MeasureTime frame
To compare micro-vessel density in oral dysplasia and squamous cell carcinoma with normal oral mucosa. Timepoint: After operative procedure—

Countries

India

Contacts

Public ContactShweta Singh

Rohilkhand Medical College and Hospital

dr.gdkatiyar@gmail.com9412544008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026